Avaliações PREreview de “Design and validation of a clinical whole genome sequencing-based assay for patient screening in a large healthcare system”

Ir para detalhes do preprint Ir para avaliações PREreview

Design and validation of a clinical whole genome sequencing-based assay for patient screening in a large healthcare system

de Josiah T. Wagner, John T. Welle, Isabelle A. Lucas Beckett, Kate R. Emery, Benjamin A. Cosgrove, Krzysztof Olszewski, Nick Wagner, Tucker C. Bower, Li Chi Yuan, Eric M. Shull, Kathleen Jade, Jon Clemens, Andrew T. Magis, Mary B. Campbell, Ora K. Gordon, Carlo B. Bifulco e Brian D. Piening

Publicado: 17 de julho de 2025
Servidor: medRxiv
DOI: 10.1101/2025.07.16.25331598

Resumo

Population genetic screening is rapidly emerging as a key methodology in the clinical laboratory for detecting actionable genomic conditions. While current clinical methods are largely focused on targeted gene panels, the increasing efficiency of next-generation sequencing (NGS) platforms permits the use of whole genome sequencing (WGS) for routine clinical applications. The key advantage of WGS is that the complete genome produced by a single sequencing event can form the basis for a patient’s genomic health care record for reanalysis throughout a patient’s lifetime. Here, we developed a scalable clinical WGS-based lab developed procedure (LDP) for heritable disease gene testing and pharmacogenomics (PGx). We performed extensive validation across a range of blood, saliva, and reference specimens. The clinical deliverable for the WGS LDP was 78 genes associated with actionable genomic conditions and 4 PGx genes. The validation cohort consisted of samples from 188 study participants that were orthogonally sequenced at commercial reference laboratories and additional reference materials. The deployed LDP was then used to sequence over 2000 patients as part of a broader clinical implementation study (“Geno4ME”). We demonstrate that the WGS LDP has excellent sensitivity, specificity, and accuracy, thus supporting WGS as a viable method for broad clinical screening.

Ler o preprint

1 PREreview

Escrever uma Avaliação PREreview Solicitar uma Avaliação PREreview

Avaliação PREreview de Ananddeep Patel

De autoria de Ananddeep Patel

Short summary of the research and contribution to the field

This preprint describes the development and validation of Geno4ME, a clinical PCR-free whole genome sequencing (WGS)-based laboratory-developed procedure (LDP) designed for population screening of actionable heritable disease genes and…

Ler a avaliação PREreview de Ananddeep Patel

Avaliações PREreview de Design and validation of a clinical whole genome sequencing-based assay for patient screening in a large healthcare system

1 PREreview

Short summary of the research and contribution to the field